| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/24/2014 | US8759282 Water-soluble films comprising low-viscosity alginates |
| 06/24/2014 | US8759279 Fragranced biodegradable film |
| 06/24/2014 | US8758831 Antiinfective free intramammary veterinary composition |
| 06/24/2014 | US8758828 Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same |
| 06/24/2014 | US8758827 Local system for the release of active principle and process for its manufacture |
| 06/24/2014 | US8758826 Cannabinoid receptor binding agents, compositions, and methods |
| 06/24/2014 | US8758825 Sequestered antagonist formulations |
| 06/24/2014 | US8758824 Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| 06/24/2014 | US8758823 Method for obtaining non-water-soluble powders having antimicrobial activity, the powders thus obtained and the antibacterial use thereof |
| 06/24/2014 | US8758822 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs |
| 06/24/2014 | US8758821 Oral formulations of ospemifene |
| 06/24/2014 | US8758820 Robust pellet |
| 06/24/2014 | US8758819 Cosmetic compositions for the treatment of skin and methods thereof |
| 06/24/2014 | US8758818 Oral tablet compositions of dexlansoprazole |
| 06/24/2014 | US8758817 Dosage form containing (S)-pantoprazole as active ingredient |
| 06/24/2014 | US8758816 Compositions comprising azelastine and methods of use thereof |
| 06/24/2014 | US8758815 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
| 06/24/2014 | US8758814 Chewable enteric coated aspirin tablets |
| 06/24/2014 | US8758813 Abuse-deterrent drug formulations |
| 06/24/2014 | US8758812 Composition for foodstuff for binding acetaldehyde |
| 06/24/2014 | US8758811 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 06/24/2014 | US8758810 Liposome compositions |
| 06/24/2014 | US8758809 Skin treatment compositions containing copper-pigment complexes |
| 06/24/2014 | US8758808 Method of making a high enhancer-loading polyacrylate formulation for transdermal applications |
| 06/24/2014 | US8758806 Human lubrication gel |
| 06/24/2014 | US8758804 Controlled and continued delivery of rifaximin and/or other substances |
| 06/24/2014 | US8758803 Film-shaped preparation comprising oily substances for oral administration |
| 06/24/2014 | US8758800 Therapeutic implant |
| 06/24/2014 | US8758799 Therapeutic implant |
| 06/24/2014 | US8758798 Therapeutic implant |
| 06/24/2014 | US8758795 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
| 06/24/2014 | US8758791 Highly compression resistant matrix with porous skeleton |
| 06/24/2014 | US8758790 Use of microcapsules for making paints and lacquers |
| 06/24/2014 | US8758784 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 06/24/2014 | US8758783 Water-in-oil emulsion comprising pigments in the water phase |
| 06/24/2014 | US8758780 Subcutaneous paliperidone composition |
| 06/24/2014 | US8758779 Pharmaceutical composition of duloxetine |
| 06/24/2014 | US8758778 Polymeric nano-carriers with a linear dual response mechanism and uses thereof |
| 06/24/2014 | US8758777 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof |
| 06/24/2014 | US8758776 Compositions and methods for treatment |
| 06/24/2014 | US8758747 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 06/24/2014 | US8758743 Compositions containing coenzyme Q10 |
| 06/24/2014 | US8758739 Cosmetic compositions containing block copolymers, tackifiers and gelling agents |
| 06/24/2014 | US8758738 Methods for sealing wounds with a sterilized composition of a cyanoacrylate monomer and a poloxamer |
| 06/24/2014 | US8758728 Foamable suspension gel |
| 06/24/2014 | US8758658 System and method for uniaxial compression of an article, such as a three dimensionally printed dosage form |
| 06/24/2014 | US8758330 Device for actively removing a target cell from blood or lymph of a vertebrate subject |
| 06/19/2014 | WO2014093976A1 Method for maintaining heterogeneous concentrations of molecules in emulsion droplets |
| 06/19/2014 | WO2014093966A1 Viral vector nanocapsule for targeting gene therapy and its preparation |
| 06/19/2014 | WO2014093918A1 Compositions and methods comprising polyethylene glycol and magnesium for treatment of neuronal injury |
| 06/19/2014 | WO2014093907A1 Pharmaceutical composition comprising antiemetic compounds and polyorthoester |
| 06/19/2014 | WO2014093836A1 Ossification-inducing composition and methods of use thereof |
| 06/19/2014 | WO2014093631A1 Formulations and carrier systems including compound interactive domains |
| 06/19/2014 | WO2014093481A1 Phenylpyrazole injectable compositions |
| 06/19/2014 | WO2014093246A1 Adhesive articles |
| 06/19/2014 | WO2014093077A1 Universal locking clip |
| 06/19/2014 | WO2014093073A1 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 06/19/2014 | WO2014092858A1 Compositions and methods for treatment of cancer |
| 06/19/2014 | WO2014092661A1 Particulate formulations of tadalafil in effervescent form |
| 06/19/2014 | WO2014092596A1 Substances and pharmaceutical compositions based thereon for treating human diseases, including chronic hepatitis b and c |
| 06/19/2014 | WO2014092419A1 Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex |
| 06/19/2014 | WO2014092358A1 Chewable tablet comprising a phosphodiesterase-5 inhibitor |
| 06/19/2014 | WO2014091729A1 基剤、及び皮膚外用剤 base and external preparation for skin |
| 06/19/2014 | WO2014091437A1 Oral form, comprising immediate-release coated particles of at least one active compound that are grinding-resistant |
| 06/19/2014 | WO2014091432A1 Pharmaceutical compositions of rifaximin |
| 06/19/2014 | WO2014091420A1 Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration |
| 06/19/2014 | WO2014091318A1 Reduced dose pharmaceutical compositions of fenofibrate |
| 06/19/2014 | WO2014091308A1 5-aminosalicylic acid capsule formulation |
| 06/19/2014 | WO2014091263A1 Telmisartan containing pharmaceutical composition |
| 06/19/2014 | WO2014091134A1 Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same |
| 06/19/2014 | WO2014091078A1 Polymeric particles-based temozolomide dosage form |
| 06/19/2014 | WO2014091035A1 Applicator and capsule for such applicator |
| 06/19/2014 | WO2014091007A1 Patch comprising an onion extract |
| 06/19/2014 | WO2014090981A1 Topical drug for treating aphthae |
| 06/19/2014 | WO2014090976A1 Copper intrauterine device |
| 06/19/2014 | WO2014090975A1 An emulsion containing a non-live medicinal substance |
| 06/19/2014 | WO2014090921A1 Transdermal delivery system |
| 06/19/2014 | WO2014090920A1 Emulsions stabilized by whey protein micelles |
| 06/19/2014 | WO2014090889A1 Oral solutions comprising folic acid |
| 06/19/2014 | WO2014090859A1 Gel compositions |
| 06/19/2014 | WO2014090858A1 Gel compositions |
| 06/19/2014 | WO2014090857A1 Gel compositions |
| 06/19/2014 | WO2014090855A1 Gel compositions |
| 06/19/2014 | WO2014090842A1 Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine |
| 06/19/2014 | WO2014090386A1 Orally disintegrating tablet containing asenapine |
| 06/19/2014 | WO2014090223A2 Compositions and solutions for colon cleansing |
| 06/19/2014 | WO2014090185A1 Application of silicon dioxide aerogel in pharmacy |
| 06/19/2014 | WO2014090176A1 Nanoscale platinum drug and preparation method thereof |
| 06/19/2014 | WO2014090174A1 Nanoscale capecitabine and preparation method therefor |
| 06/19/2014 | WO2014090173A1 Nanoscale doxorubicin hydrochloride and preparation method therefor |
| 06/19/2014 | WO2014090171A1 Nanoscale cyclophosphamide and preparation method thereof |
| 06/19/2014 | WO2014090169A1 Nanoscale paclitaxel and preparation method thereof |
| 06/19/2014 | WO2014090168A1 Nanoscale docetaxel and preparation method thereof |
| 06/19/2014 | WO2014090167A1 Nanoscale insulin and preparation method thereof |
| 06/19/2014 | WO2014090122A1 Pharmaceutical compositions for reducing sugar level, preparation methods and applications thereof |
| 06/19/2014 | WO2014089957A1 Stable busulfan injection |
| 06/19/2014 | WO2014089649A1 Nanofibres containing controlled release active substance for odontological application and method |
| 06/19/2014 | WO2014077712A8 Solid lipid nanoparticles of roxithromycin for hair loss or acne |
| 06/19/2014 | WO2014064711A3 Methods of administering raltegravir and raltegravir compositions |
| 06/19/2014 | WO2014049606A3 Capsule for encapsulating a tablet |